KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Tax Provisions: 2018-2025

Historic Tax Provisions for Xenon Pharmaceuticals (XENE) over the last 8 years, with Sep 2025 value amounting to $677,000.

  • Xenon Pharmaceuticals' Tax Provisions rose 311.56% to $677,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year increase of 1331.84%. This contributed to the annual value of $4.8 million for FY2024, which is 1735.27% up from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Tax Provisions of $677,000 as of Q3 2025, which was up 208.15% from -$626,000 recorded in Q2 2025.
  • In the past 5 years, Xenon Pharmaceuticals' Tax Provisions registered a high of $5.0 million during Q4 2024, and its lowest value of -$626,000 during Q2 2025.
  • For the 3-year period, Xenon Pharmaceuticals' Tax Provisions averaged around $451,000, with its median value being -$157,000 (2023).
  • Within the past 5 years, the most significant YoY rise in Xenon Pharmaceuticals' Tax Provisions was 3,557.14% (2021), while the steepest drop was 6,700.00% (2021).
  • Quarterly analysis of 5 years shows Xenon Pharmaceuticals' Tax Provisions stood at $484,000 in 2021, then skyrocketed by 144.42% to $1.2 million in 2022, then crashed by 117.33% to -$205,000 in 2023, then spiked by 2,546.83% to $5.0 million in 2024, then surged by 311.56% to $677,000 in 2025.
  • Its last three reported values are $677,000 in Q3 2025, -$626,000 for Q2 2025, and $427,000 during Q1 2025.